Read More

Veteran Trader Peter Brandt Warns Of Impending Regulatory Crackdown On Crypto Staking: ‘It’s Going To Be A Bloodbath’

Veteran trader Peter Brandt has sparked a discussion within the cryptocurrency community with his recent remarks on X. What Happened: On Thursday, Brandt predicted a severe regulatory crackdown on crypto staking, describing the future landscape as a “bloodbath.”

BTC

Read More

Trump’s China Tariff Hikes Could Smother US Economic Growth: Fitch Ratings Sounds Alarm

Fitch Ratings warns of economic fallout from Trump's proposed trade tariffs if he wins 2020 election. US GDP could decline by 0.4-1.1%, and inflation may decrease in long term. US trading partners could see even greater declines, with China, Canada, and Mexico at risk. Trade imbalance blamed on savings and investment disparity, not tariffs.

GXC

Read More

Analysts’ Varied Perspectives On CytomX’s CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer

Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated patients with advanced metastatic solid tumors. Reductions observed, especially in pancreatic cancer, with stable disease maintained.

CTMX